Fox Chase Cancer Center and U.S. Post Office Unveil New Prostate Cancer Stamp Today
PHILADELPHIA (June 18, 1999) -- Just in time for Father's Day, prostate cancer survivors and fathers join the Fox Chase branch of the U.S. Post Office to unveil the first prostate cancer stamp today, Friday, June 18, at 3:30 p.m. in the Center's cafeteria.
Paul Engstrom, M.D., senior vice president for population science at Fox Chase, will host the event. He was diagnosed with prostate cancer in 1996. Dr. Engstrom will speak about his experience with the disease and the courage it takes cancer victims to fight prostate cancer emotionally and physically. He will also discuss the Prostate Cancer Risk Assessment Program at Fox Chase.
The Prostate Cancer Risk Assessment Program is designed to increase awareness and provide education about prostate cancer to help cancer patients, their families and men who may be at increased risk of the disease. The program has three main goals: to offer clients education about prostate cancer risks; to provide close monitoring to detect any tumors at the earliest and most curable stage; and to collect data on possible risk factors that will aid research to help the next generation of men likely to be affected by prostate cancer.
Tom McClay is a prostate cancer survivor who will also help in the stamp unveiling. McClay was treated at Fox Chase and spoke publicly about his battle against prostate cancer. He will be honored for his dedication to prostate cancer awareness.
The U.S. Post Office has issued more than 70 million prostate cancer stamps nationwide, continuing its tradition of raising awareness of significant health and social issues in this country. Jane Maull, a representative of the Post Master at the Fox Chase branch, will speak about this tradition and the special contribution this stamp will make toward spreading awareness of prostate cancer. The stamps will be available during the ceremony and at your local post office.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research including prevention, detection and treatment of cancer, and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.